Saveetha University's DFT Study of "DTPB" in Results in Chemistry Describes Penoxsulam, a Rice Herbicide: What It Means for Computational Drug Discovery
A Saveetha University DFT study describes the rice herbicide penoxsulam
Quentir Medicine Monitor
Evidence-based insights for quantum medicine.
A computational chemistry paper from Saveetha University in Chennai presents a fluorinated sulfonamide called DTPB as a molecule with nonlinear optical promise and a possible starting point for drug design. The full chemical name in its title identifies the same compound as the registered rice herbicide penoxsulam, and the paper's abstract does not use that name.
The study appeared in Results in Chemistry, volume 31, as article 103949, and was covered on 11 October 2026 by the science news site Bioengineer.org under the headline that quantum chemistry "reveals hidden power" in the molecule. For a reader who follows computational drug discovery, the paper is a useful case in how to read a calculated portrait of a compound: what the calculations can establish, what they cannot, and what a quick lookup in a public chemical database adds before anyone talks about medicine.
The authors are L. Sasikala, P. V. Avinash, M. Suganthi, A. Suvitha, Sheeba Britto, S. Vimal and Marimuthu Prabhaharan, four of them listed at Saveetha University and one at St. Joseph's Institute of Technology. The article is open access under the DOI 10.1016/j.rechem.2026.103949.
The team used density functional theory, the standard quantum-mechanical method for computing a molecule's electron structure on ordinary computers, at the B3LYP/6-311G(d,p) level. According to the abstract, the optimized geometry is well defined, and the gap between the highest occupied and lowest unoccupied molecular orbitals falls between 4.61 and 4.89 electronvolts across the solvent models used. The authors read that as moderate stability with favorable internal charge transfer.
The headline number concerns optics. The calculated first-order hyperpolarizability is 1.5 × 10-30 electrostatic units, which the abstract puts at about eleven times the value for urea, a common reference material. Maps of electrostatic potential and electron localization point to the oxygen- and nitrogen-containing regions as the reactive sites. A graph-theory section reports topological indices of 170, 201 and 878.
Phasecraft's 3,000-Emulation VQE Molecular Dataset With NVIDIA Was Computed on GPUs Under Wellcome Leap's Q4Bio: What the 14 September 2026 Announcement Shows
Quentir Medicine Monitor
Evidence-based insights for quantum medicine.
Phasecraft and NVIDIA announced on 14 September 2026 what Phasecraft calls the largest known database of Variational Quantum Eigensolver results for molecules, more than 3,000 emulations across thirteen molecular systems, computed on NVIDIA Hopper GPUs at the University of Nottingham. No quantum computer ran any of it, and the announcement says so in its own description of the method.
The dataset is an emulated VQE molecular dataset: for each of the 13 molecular systems, a classical GPU cluster worked out what a quantum processor of 4 to 32 qubits would return when asked for the lowest-energy state of the molecule, with most of the circuits in the 24-to-28-qubit range. Its purpose is to train Phasecraft's quantum-enhanced density functional theory method, a way of improving the standard workhorse of computational chemistry with data a quantum computer would produce. The Wellcome Leap Q4Bio program that paid for it asks whether new algorithms can deliver quantum advantage for health, and its prizes require a demonstration on a real quantum computer with more than 50 qubits. For a hospital buyer or a clinical pharmacologist the announcement describes training data for a chemistry method, produced on conventional hardware, with no named molecular systems, quantitative accuracy benchmarks or clinical results disclosed.
The Phasecraft release, datelined London and Toronto, gives four numbers: over 3,000 unique emulations, 13 molecular systems, a qubit range of 4 to 32 with "the vast majority in the 24–28 qubit regime", and "a 15x simulation speedup over prior results when modeling physical, many-body systems integral to biology and health applications". The GPUs were NVIDIA Hopper hardware hosted at the University of Nottingham, driven through NVIDIA's cuQuantum software kit. Ashley Montanaro, Phasecraft's co-founder and chief executive, is quoted on the need "to push the limits of today's most capable hardware, both conventional and quantum"; Sam Stanwyck, NVIDIA's director of quantum product, on shortening "the timeline" to useful quantum computing. The release describes the dataset as "a training foundation for quantum-enhanced molecular modeling, which could accelerate drug discovery at a scale previously out of reach, as quantum hardware develops". The conditional clause at the end carries the weight of the sentence.